Colitis ulcerosa: vizsgálatok itt: Dél-Korea

In Dél-Korea 24 Also abroad 382

24 trials · From ClinicalTrials.gov, checked 2026. november 10.. Ask the study team whether a trial fits you.

2. fázisCsak meghívásos
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
Where
Busan, Daegu, Daejeon, Seoul, Wŏnju
Életkor
18 év and over
People
645 worldwide
Run by
Spyre Therapeutics, Inc.
See details and how to joinNCT07652294 · EU 2025-524640-35-00
2. fázisTaking people
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Where
Busan, Daegu, Daejeon, Gwangju, Gyeongsan-si, Pusan, Seoul, Wŏnju
Életkor
18 év to 80 év
People
1431 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07415044
3. fázisTaking people
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Where
Seoul
Életkor
3 év to 64 év
People
196 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00
3. fázisTaking people
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Where
Ansan, Busan, Daejeon, Ganggu, Seoul, Tongdaemun-Gu
Életkor
18 év and over
People
644 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT07577856 · EU 2026-525923-26-00
2. fázisTaking people
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Where
Busan, Daejeon, Gwangju, Seoul, Wŏnju
Életkor
18 év and over
People
224 worldwide
Run by
Genentech, Inc.
See details and how to joinNCT06979336 · EU 2025-520690-39-00
2. fázisTaking people
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Where
Busan, Daegu, Daejeon, Seoul, Suwon, Wŏnju
Életkor
18 év to 75 év
People
645 worldwide
Run by
Spyre Therapeutics, Inc.
See details and how to joinNCT07012395 · EU 2025-521242-26-00
3. fázisTaking people
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
Where
Seoul, Yangsan
Életkor
2 év to 17 év
People
120 worldwide
Run by
AbbVie
See details and how to joinNCT07071519 · EU 2024-514695-41-00
2. fázisTaking people
A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
Where
Ansan-si, Seoul, Wŏnju
Életkor
18 év to 75 év
People
100 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07463183 · EU 2025-523479-49-00
3. fázisTaking people
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Where
Ansan-si, Busan, Daegu, Seoul, Suwon
Életkor
16 év to 80 év
People
751 worldwide
Run by
Sanofi
See details and how to joinNCT07185009
3. fázisTaking people
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Where
Daegu, Seoul
Életkor
2 év to 17 év
People
70 worldwide
Run by
Takeda
See details and how to joinNCT06405087 · EU 2023-508804-39-00
3. fázisTaking people
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Where
Deagu, Seoul
Életkor
2 év to 19 év
People
150 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT04844606
3. fázisTaking people
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
Where
Daegu, Seoul
Életkor
2 év to 17 év
People
70 worldwide
Run by
Takeda
See details and how to joinNCT06100289 · EU 2023-503188-40-00
No phaseTaking people
A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants
Where
Ansan, Bucheon-si, Busan, Changwon, Cheonan, Cheongju-si, Chuncheon, Daegu, Daejeon, Goyang-si, Gwangju, Gwangmyeong, Incheon, Jeju City, Jeonju, Jinju, Sejong, Seongnam-si, Seoul, Suwon, Uijeongbu-si, Wŏnju, Yangsan, Yŏngin
Életkor
18 év and over
People
2040
Run by
Eisai Korea Inc.
See details and how to joinNCT06246123
2. fázisTaking people
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
Where
Haeundae, Wŏnju
Életkor
18 év to 75 év
People
192 worldwide
Run by
Takeda
See details and how to joinNCT06764615 · EU 2024-518914-18-00
3. fázisTaking people
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Where
Daegu, Incheon, Seoul
Életkor
2 év to 17 év
People
240 worldwide
Run by
Takeda
See details and how to joinNCT05442567 · EU 2023-509046-36-00
No phaseTaking people
Predictors of Prognosis in IBD Patients
Where
Seongnam-si
Életkor
18 év and over
People
100
Run by
Seoul National University Bundang Hospital
See details and how to joinNCT05653011
No phaseTaking people
A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea
Where
Goyang-si
Életkor
18 év and over
People
600
Run by
Takeda
See details and how to joinNCT05428345
No phaseCsak meghívásos
Research for the Precision Medicine in the Treatment of Inflammatory Bowel Disease
Where
Seoul
Életkor
10 év and over
People
2000
Run by
Seoul National University Hospital
See details and how to joinNCT07166588
2/3. fázisCsak meghívásos
Long-term Efficacy and Safety of Fecal Microbiota Transplantation in Patients With Ulcerative Colitis
Where
Seoul
Életkor
10 év to 80 év
People
30
Run by
Seoul National University Hospital
See details and how to joinNCT07154784
No phaseTaking people
SNU IBD Cohort Study : Searching for Characterization of High Risk Populations for Developing Inflammatory Bowel Disease
Where
Seoul
Életkor
10 év and over
People
500
Run by
Seoul National University Hospital
See details and how to joinNCT07011979
No phaseTaking people
A Post-Marketing Surveillance Study to Assess Safety of Ozanimod in Patients With Moderate to Severe Active UC in Korea
Where
Seoul
Életkor
19 év and over
People
3000
Run by
Bristol-Myers Squibb
See details and how to joinNCT06073873
No phaseTaking people
Gut Microbiome in Inflammatory Bowel Disease
Where
Seoul
People
1500
Run by
Kyunghee University Medical Center
See details and how to joinNCT03589183
No phaseTaking people
Prediction Model for Response to Biologics and Small Molecular Agent for UC
Where
Seoul
Életkor
18 év to 79 év
People
300
Run by
Asan Medical Center
See details and how to joinNCT05186623
No phaseTaking people
Epidemiology of Inflammatory Bowel Disease in the Songpa-Kangdong District, Seoul, Korea.
Where
Seoul
People
2000
Run by
Asan Medical Center
See details and how to joinNCT01731665